GALECTIN THERAPEUTICS INC — Director's Dealing 2021

Jan 19, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GALECTIN THERAPEUTICS INC (GALT)
CIK: 0001133416
Period of Report: 2021-01-11

Reporting Person: AMELIO GILBERT F (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-11	Common Stock	S	60000	$2.17	Disposed	60614	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price, rounded to the nearest cent. The shares were sold in multiple transactions at prices ranging from $2.16 to $2.22 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased by the Reporting Person at each separate price on each date of purchase.